Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 7
2020 4
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Challenges and Opportunities for Biomarker Validation.
Hey SP, D'Andrea E, Jung EH, Tessema F, Luo J, Gyawali B, Kesselheim AS. Hey SP, et al. Among authors: tessema f. J Law Med Ethics. 2019 Sep;47(3):357-361. doi: 10.1177/1073110519876162. J Law Med Ethics. 2019. PMID: 31560620
Physician Perceptions of Step Therapy Prescribing Requirements.
Fischer MA, Kesselheim AS, Lu Z, Ross KM, Tessema FA, Avorn J. Fischer MA, et al. Among authors: tessema fa. J Manag Care Spec Pharm. 2019 Nov;25(11):1210-1224. doi: 10.18553/jmcp.2019.25.11.1210. J Manag Care Spec Pharm. 2019. PMID: 31663459
Public funding for transformative drugs: the case of sofosbuvir.
Barenie RE, Avorn J, Tessema FA, Kesselheim AS. Barenie RE, et al. Among authors: tessema fa. Drug Discov Today. 2021 Jan;26(1):273-281. doi: 10.1016/j.drudis.2020.09.024. Epub 2020 Oct 1. Drug Discov Today. 2021. PMID: 33011345 Free PMC article. Review.
Generic Competition for Drugs Treating Rare Diseases.
Beall RF, Quinn AE, Kesselheim AS, Tessema FA, Sarpatwari A. Beall RF, et al. Among authors: tessema fa. J Law Med Ethics. 2020 Dec;48(4):789-795. doi: 10.1177/1073110520979391. J Law Med Ethics. 2020. PMID: 33404340 No abstract available.
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page